Opthea Limited
Opthea Limited (CKDXF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ckdxf · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Opthea Limited (CKDXF) measures how much investors pay for each dollar of the company's trailing earnings. CKDXF's current PE ratio of N/A is calculated by dividing its stock price of $0.44 by its TTM earnings per share of -$0.07.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Opthea LimitedYou CKDXF | $602M | N/A | — | -$0.07 |
 Adcock Ingram Holdings Limited AIHLF | $624M | 7.40x | +99.9% | $5.85 |
 AnGes, Inc. AMGXF | $143M | N/A | — | -$14.45 |
 Columbia Care Inc. CCHWF | $521M | N/A | — | -$0.26 |
 Claritas Pharmaceuticals, Inc. CLAZF | $0M | 0.00x | -99.9% | $0.16 |
 Dong Fang Hui Le Inc. DFHL | $400M | N/A | — | -$0.00 |
 Inventiva S.A. IVEVF | $556M | N/A | — | -$1.90 |
Industry Average 2 peers with valid PE | — | 3.70x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-0.13 | — | |
2024-06-30 FY2024 | — | $-0.35 | — | |
2023-06-30 FY2023 | — | $-0.45 | — | |
2022-06-30 FY2022 | — | $-0.34 | — | |
2021-06-30 FY2021 | — | $-0.18 | — | |
2020-06-30 FY2020 | — | $-0.06 | — | |
2019-06-30 FY2019 | — | $-0.09 | — | |
2018-06-30 FY2018 | — | $-0.07 | — | |
2017-06-30 FY2017 | — | $-0.03 | — | |
2016-06-30 FY2016 | — | $-0.04 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Opthea Limited (CKDXF) measures how much investors pay for each dollar of the company's trailing earnings. CKDXF's current PE ratio of N/A is calculated by dividing its stock price of $0.44 by its TTM earnings per share of -$0.07.
Frequently asked questions
CKDXF pe ratio · 6 questionsCKDXF's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.44 and TTM EPS of -$0.07. Data sourced from Financial Modeling Prep via CKDXF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Opthea Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08